Group 1 - The core viewpoint of the news highlights the performance of Qianhai Kaiyuan Medical Health A and C funds, which experienced declines of 1.82% and 1.83% respectively in August, while the Shanghai Composite Index rose by 7.97% during the same period [1][2] - Since their inception on January 19, 2018, the cumulative returns for Qianhai Kaiyuan Medical Health A and C funds are 37.51% and 36.47% respectively, with a decline of 10.71% and 10.98% over the past three years [1] - As of June 30, 2025, the total scale of Qianhai Kaiyuan Medical Health A and C funds is 1.011 billion yuan [1] Group 2 - The top ten holdings of Qianhai Kaiyuan Medical Health A/C funds include companies such as Sanofi, Dizh Medical, Innovent Biologics, and others [1] - The fund is currently managed by Fan Jie, who has been with Qianhai Kaiyuan Fund Management Company since 2014 and has held various positions including research analyst and investment manager [1]

Summary of Key Points Core Viewpoint - The stock and mixed funds experienced a mixed performance on June 10, with only 19.99% achieving positive returns, while a significant number of funds faced declines exceeding 2% [1][2]. Fund Performance - Among stock and mixed funds, 68 funds reported returns exceeding 2%, with the top performer being Qianhai Kaiyuan Medical Health C, which achieved a net value growth rate of 2.78% [1][2]. - The average net value growth rate for these funds on June 10 was -0.46% [1]. Sector Performance - The Shanghai Composite Index fell by 0.44%, closing at 3384.82 points, while the Shenzhen Component Index and the ChiNext Index dropped by 0.86% and 1.17%, respectively [1]. - The leading sectors in terms of growth included Beauty Care (up 1.10%), Banking (up 0.48%), and Pharmaceutical & Biological (up 0.33%) [1]. Fund Types - The top-performing fund, Qianhai Kaiyuan Medical Health C, belongs to the flexible allocation category, while 27 funds in the positive growth category are classified as equity funds [2]. - Among the funds that experienced a decline, the largest drop was recorded by AVIC Vision Leading Mixed Initiation A, with a net value decrease of 3.43% [2][4]. Fund Company Performance - In the list of funds with net value growth rates exceeding 2%, Huashan Fund had 8 funds, while both Fortune Fund and Ping An Fund had 6 funds each [1][2].